The healthcare sector is one of the largest and most complex in the world, spanning a diverse range of industries, such as drug manufacture, medical equipment, health insurance, healthcare facilities (e.g. clinics and hospitals) and so on.

Deloitte anticipates global healthcare expenditures to continue to rise alongside spending, which is projected to increase at 5.4% a year between 2017 and 2022, growing from $7.7trln to $10trln. With ageing populations, chronic diseases prevailing and the exponential growth of often costly digital innovations, the value of healthcare is only likely to go up.

Why invest in healthcare?

Advances in healthcare offer great potential to the UK's health service. The problem? It can be difficult for these opportunities to secure investment since they can take many years of R&D to hit the market. Meanwhile, the prevalence of non-communicable diseases such as cancer, heart disease and diabetes continues to climb.

The only way to meet the growing demands of the sector is to facilitate innovative new treatments and infrastructure through technology, making global healthcare more sustainable. That's where the opportunity for versatile young businesses – and the investors that can make them happen – comes in.

If you're an investor who is happy to wait seven-plus years for any return so long as your investment has the potential to improve people's lives for generations to come, healthcare might be the sector for you.

Why invest with SyndicateRoom?

SyndicateRoom gives investors access to growing businesses across many different sectors, including healthcare. Unlike most investing platforms for startups, which tend to specialise in consumer industries and fund few healthcare businesses, SyndicateRoom has a history of attracting companies from the life sciences – healthcare, medtech, biotech, pharma and so on.

In 2015, SyndicateRoom was named Europe’s leading online platform for life science investment in a report by Biocom, having funded 16 of the 42 life science projects up to that date. Today, 33% of the businesses that seek funding through our platform fall into this category (2019). This trend is due in large part to the fact that the investors that use SyndicateRoom tend to be hunting for long-term investments with the potential to make a significant difference worldwide – in simple terms, ones that want to make the world a better place.

Some recent healthcare startups our members helped fund are Camallergy, a business developing life-changing treatments for people with food allergies, starting with peanuts; PatientSource, software that enables medical records to be stored electronically; MGB Biopharma, a business developing a new class of anti-infective medicine.

As with any investment portfolio, diversification is a key strategy to help mitigate your risk. SyndicateRoom enables you to invest in businesses from many different sectors through a single, easy-to-use platform. Want to simplify the process even further? Let our data-driven Access EIS fund build a diversified startup portfolio for you.

What SyndicateRoom offers:

  1. SyndicateRoom is the only EIS fund that uses data to build you a portfolio of early stage business co-invested in with some of the UK's top performing business angels.

  2. Investors receive the same class of shares no matter how much they invest

  3. Equity crowdfunding offers you the opportunity to create a diversified investment portfolio

  4. Investors that qualify can benefit from tax relief through the Enterprise Investment Scheme and SEIS scheme

SyndicateRoom is FREE to join

With SyndicateRoom you gain access to invest alongside professional investors receiving the same share class and same share price.